These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1697861)

  • 1. Termination of DNA synthesis by 9-beta-D-arabinofuranosyl-2-fluoroadenine. A mechanism for cytotoxicity.
    Huang P; Chubb S; Plunkett W
    J Biol Chem; 1990 Sep; 265(27):16617-25. PubMed ID: 1697861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the 3' --> 5' exonuclease of human DNA polymerase epsilon by fludarabine-terminated DNA.
    Kamiya K; Huang P; Plunkett W
    J Biol Chem; 1996 Aug; 271(32):19428-35. PubMed ID: 8702631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate pharmacokinetics in plasma and tumor cells of patients with relapsed leukemia and lymphoma.
    Danhauser L; Plunkett W; Keating M; Cabanillas F
    Cancer Chemother Pharmacol; 1986; 18(2):145-52. PubMed ID: 2431803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the actions of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine on target enzymes from mouse tumor cells.
    White EL; Shaddix SC; Brockman RW; Bennett LL
    Cancer Res; 1982 Jun; 42(6):2260-4. PubMed ID: 7042080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action of 9-beta-D-arabinofuranosyl-2-fluoroadenine on RNA metabolism.
    Huang P; Plunkett W
    Mol Pharmacol; 1991 Apr; 39(4):449-55. PubMed ID: 1708088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5'-triphosphate.
    Parker WB; Shaddix SC; Chang CH; White EL; Rose LM; Brockman RW; Shortnacy AT; Montgomery JA; Secrist JA; Bennett LL
    Cancer Res; 1991 May; 51(9):2386-94. PubMed ID: 1707752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism and action of fludarabine phosphate.
    Plunkett W; Huang P; Gandhi V
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):3-17. PubMed ID: 1699280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of fludarabine and 1-beta-D-arabinofuranosylcytosine 5'-triphosphates by DNA polymerase alpha: affinity, interaction, and consequences.
    Gandhi V; Huang P; Chapman AJ; Chen F; Plunkett W
    Clin Cancer Res; 1997 Aug; 3(8):1347-55. PubMed ID: 9815818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual mode of inhibition of purified DNA ligase I from human cells by 9-beta-D-arabinofuranosyl-2-fluoroadenine triphosphate.
    Yang SW; Huang P; Plunkett W; Becker FF; Chan JY
    J Biol Chem; 1992 Feb; 267(4):2345-9. PubMed ID: 1310314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of c-Jun kinase in the apoptotic response to nucleoside analogue-induced DNA damage.
    Sampath D; Plunkett W
    Cancer Res; 2000 Nov; 60(22):6408-15. PubMed ID: 11103806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of inhibition of deoxyribonucleic acid synthesis by 1-beta-D-arabinofuranosyladenosine triphosphate and its potentiation by 6-mercaptopurine ribonucleoside 5'-monophosphate.
    Lee MY; Byrnes JJ; Downey KM; So AG
    Biochemistry; 1980 Jan; 19(1):215-9. PubMed ID: 6153266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro biological activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine and the biochemical actions of its triphosphate on DNA polymerases and ribonucleotide reductase from HeLa cells.
    Tseng WC; Derse D; Cheng YC; Brockman RW; Bennett LL
    Mol Pharmacol; 1982 Mar; 21(2):474-7. PubMed ID: 7048062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of 9-beta-D-arabinofuranosyl-2-fluoroadenine into HL-60 cellular RNA and DNA.
    Spriggs D; Robbins G; Mitchell T; Kufe D
    Biochem Pharmacol; 1986 Jan; 35(2):247-52. PubMed ID: 3942598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of hepatitis B virus deoxyribonucleic acid polymerase by the 5'-triphosphates of 9-beta-D-arabinofuranosyladenine and 1-beta-D-arabinofuranosylcytosine.
    Hess G; Arnold W; Meyer zum Büschenfelde KH
    Antimicrob Agents Chemother; 1981 Jan; 19(1):44-50. PubMed ID: 6166246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of 2-F-ara-A (9-beta-D-arabinofuranosyl-2-fluoroadenine) in cancer patients during the phase I clinical investigation of fludarabine phosphate.
    Malspeis L; Grever MR; Staubus AE; Young D
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):18-32. PubMed ID: 1699279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of primer RNA formation in CCRF-CEM leukemia cells by fludarabine triphosphate.
    Catapano CV; Chandler KB; Fernandes DJ
    Cancer Res; 1991 Apr; 51(7):1829-35. PubMed ID: 1706219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primer RNA chain termination induced by 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-triphosphate. A mechanism of DNA synthesis inhibition.
    Catapano CV; Perrino FW; Fernandes DJ
    J Biol Chem; 1993 Apr; 268(10):7179-85. PubMed ID: 7681821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between the plasma and intracellular pharmacology of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate in patients with relapsed leukemia.
    Danhauser L; Plunkett W; Liliemark J; Gandhi V; Iacoboni S; Keating M
    Leukemia; 1987 Sep; 1(9):638-43. PubMed ID: 3478543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of the 5'-triphosphates of 9-beta-(2'-azido-2'-deoxy-D-arabinofuranosyl)adenine and 9-beta-D-arabinofuranosyladenine on DNA polymerases from L1210 leukemia cells.
    Allaudeen HS; Kozarich JW; Sartorelli AC
    Nucleic Acids Res; 1982 Feb; 10(4):1379-87. PubMed ID: 6175955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to 9-beta-D-arabinofuranosyl-2-fluoroadenine due to reduced incorporation into DNA from competition by excess deoxyadenosine triphosphate: implications for different sensitivities to nucleoside analogues.
    Yoshio N; Kawai Y; Hori H; Ueda T
    Int J Hematol; 2005 Jun; 81(5):405-12. PubMed ID: 16158821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.